Cargando…
Administration route governs the therapeutic efficacy, biodistribution and macrophage targeting of anti-inflammatory nanoparticles in the lung
BACKGROUND: Uncontrolled inflammation is a central problem for many respiratory diseases. The development of potent, targeted anti-inflammatory therapies to reduce lung inflammation and re-establish the homeostasis in the respiratory tract is still a challenge. Previously, we developed a unique anti...
Autores principales: | Wang, Lu, Rao, Yafei, Liu, Xiali, Sun, Liya, Gong, Jiameng, Zhang, Huasheng, Shen, Lei, Bao, Aihua, Yang, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905431/ https://www.ncbi.nlm.nih.gov/pubmed/33632244 http://dx.doi.org/10.1186/s12951-021-00803-w |
Ejemplares similares
-
Therapeutic efficacy of nanoparticles and routes of administration
por: Chenthamara, Dhrisya, et al.
Publicado: (2019) -
Impact of administration route on nanocarrier biodistribution in a murine colitis model
por: Applegate, Catherine C., et al.
Publicado: (2022) -
Manipulation of macrophage polarization by peptide-coated gold nanoparticles and its protective effects on acute lung injury
por: Wang, Lu, et al.
Publicado: (2020) -
Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting
por: Wiklander, Oscar P. B., et al.
Publicado: (2015) -
Biodistribution and Toxicity of Micellar Platinum Nanoparticles in Mice via Intravenous Administration
por: Brown, Anna L., et al.
Publicado: (2018)